13F GuideFiling Basics
What is SEC Form 13F? Ultimate Guide to Institutional Equity Filings
Learn how SEC Form 13F filings work, the $100M threshold, 45-day reporting lag, and how to track top hedge fund holdings.
AlphaSMO Research GuideRead Guide
CIK: 0001447228
Total reported value
$291.3M
$291.3M
21 檔
817.5%
As reported in its official Q4 2024 Form 13F filing, Yiheng Capital Management, L.P.'s tracked investment portfolio stood at $291.3M with 21 total positions.
In Q4 2024, Yiheng Capital Management, L.P. displayed an active expansion posture, initiating 5 new positions and adding to 6 existing holdings, outstripping position reductions.
| # | Ticker | Issuer | Asset Subclass | Weight | Weight Change | Shares Change | 4Q Trend |
|---|---|---|---|---|---|---|---|
| 1 | JD | Jd.com Inc-adr | Stock-Consumer Disc | 53.38% | +5.02% | +95.53% | |
| 2 | BILI | Bilibili Inc-sponsored Adr | Stock-Other | 29.44% | +5.11% | +23.93% | |
| 3 | ALAB | Astera Labs Inc | Stock-Tech | 4.17% | — | — | |
| 4 | NOAH | Noah Holdings Ltd-spon Ads | Stock-Other | 3.03% | -5.79% | — | |
| 5 | HTHT | H World Group Ltd-adr | Stock-Other | 1.66% | -2.42% | -18.55% | |
| 6 | EDU | New Oriental Educatio-sp Adr | Stock-Consumer Staples | 1.28% | +1.79% | — | |
| 7 | RBLX | Roblox CORP -class A | Stock-Comm Services | 1.28% | — | +14.57% | |
| 8 | SMCI | Super Micro Computer Inc | Stock-Tech | 1.06% | — | — | |
| 9 | TAL | Tal Education Group- Adr | Stock-Consumer Staples | 0.84% | -1.25% | — | |
| 10 | AKRO | Akero Therapeutics Inc | Stock-Other | 0.71% | — | -12.21% | |
| 11 | MBLY | Mobileye Global Inc-a | Stock-Other | 0.58% | — | — | |
| 12 | VRDN | Viridian Therapeutics Inc | Stock-Other | 0.55% | +0.76% | -11.51% | |
| 13 | DNLI | Denali Therapeutics Inc | Stock-Other | 0.55% | — | +16.66% | |
| 14 | BEAM | Beam Therapeutics Inc | Stock-Other | 0.41% | +0.03% | -44.21% | |
| 15 | ACMR | Acm Research Inc-class A | Stock-Other | 0.40% | — | +2.15% | |
| 16 | RERE | Atrenew Inc | Stock-Other | 0.35% | -2.23% | +107.65% | |
| 17 | IVA | Inventiva SA - Adr | Stock-Other | 0.22% | — | — | |
| 18 | DBVT | Dbv Technologies Sa-spon Adr | Stock-Other | 0.08% | -0.58% | — | |
| 19 | TOUR | Tuniu Corp-spon Adr | Stock-Other | 0.01% | -0.10% | EXIT | |
| 20 | GBIOGBX | Generation Bio Co | Stock-Other | 0.01% | — | — | |
| 21 | YSG | Yatsen Holding Ltd-adr | Stock-Other | — | -0.04% | — |
| # | Ticker | Issuer | Weight Change | Shares Change | Action |
|---|---|---|---|---|---|
| 1 | JD | Jd.com Inc-adr | +11.4% | +95.53% | Add |
| 2 | ALAB | Astera Labs Inc | +4.2% | NEW | New buy |
| 3 | SMCI | Super Micro Computer Inc | +1.1% | NEW | New buy |
| 4 | MBLY | Mobileye Global Inc-a | +0.6% | NEW | New buy |
| 5 | RBLX | Roblox CORP -class A | +0.1% | +14.57% | Add |
| 6 | RERE | Atrenew Inc | +0.1% | +107.65% | Add |
| 7 | DBVT | Dbv Technologies Sa-spon Adr | +0.1% | NEW | New buy |
| 8 | YSG | Yatsen Holding Ltd-adr | — | NEW | New buy |
| 9 | GBIOGBX | Generation Bio Co | 0% | — | Unchanged |
| 10 | TOUR | Tuniu Corp-spon Adr | 0% | — | Unchanged |
| 11 | IVA | Inventiva SA - Adr | 0% | — | Unchanged |
| 12 | ✓ | Dbv Technologies S A | -0.1% | EXIT | Sold out |
| 13 | ACMR | Acm Research Inc-class A | -0.3% | +2.15% | Add |
| 14 | DNLI | Denali Therapeutics Inc | -0.4% | +16.66% | Add |
| 15 | AKRO | Akero Therapeutics Inc | -0.4% | -12.21% | Trim |
| 16 | VRDN | Viridian Therapeutics Inc | -0.4% | -11.51% | Trim |
| 17 | TAL | Tal Education Group- Adr | -0.5% | — | Unchanged |
| 18 | BEAM | Beam Therapeutics Inc | -0.6% | -44.21% | Trim |
| 19 | EDU | New Oriental Educatio-sp Adr | -0.7% | — | Unchanged |
| 20 | NOAH | Noah Holdings Ltd-spon Ads | -1.2% | — | Unchanged |
| 21 | HTHT | H World Group Ltd-adr | -1.4% | -18.55% | Trim |
| 22 | BILI | Bilibili Inc-sponsored Adr | -11.5% | +23.93% | Add |
According to official SEC Form 13F filings, Yiheng Capital Management, L.P. reported a total U.S. public equity portfolio value of $291.3M across 21 disclosed positions in Q4 2024.
Expert Analysis & Guides for Tracking Wall Street Smart Money Movements
Learn how SEC Form 13F filings work, the $100M threshold, 45-day reporting lag, and how to track top hedge fund holdings.
In terms of portfolio concentration, the top 5 core holdings (including JD, BILI, ALAB) accounted for 817.5% of total reported equity market value during Q4 2024.
Top New Position Initiated
ALAB
市值: $108.4M
Top Position Liquidated / Trimmed
DBV TECHNOLOGIES S A
前期市值: $2.2M
During Q4 2024, Yiheng Capital Management, L.P.'s top holdings by market value included JD (53.4%)、BILI (29.4%)、ALAB (4.2%). The largest single position, JD, represented 53.4% of total portfolio value.
In Q4 2024, Yiheng Capital Management, L.P. made 16 total portfolio adjustments, initiating 5 new buys, adding to 6 positions, trimming 4 holdings, and fully liquidating 1 stocks.
All holding records on this page are fetched directly from the U.S. Securities and Exchange Commission (SEC) EDGAR system (Form 13F-HR). AlphaSMO parses CUSIP identifiers and formats data into Schema.org-compliant datasets.
Understand SEC Form 4 insider disclosures for corporate officers, directors, and 10% owners to track executive transactions.
Understand Rule 144 restricted stock sale notices to spot planned insider liquidations before market sell pressure arrives.
Explore the 5% beneficial ownership threshold, 13D vs 13G filing differences, and recent SEC accelerated deadline rules.
Best practices for analyzing 13F quarterly changes without getting misled by stock splits, options, or market valuation drift.
Learn how AlphaSMO's flagship signal detects high-conviction stocks where 13F hedge funds and corporate insiders buy at the same time.